About Verismo Therapeutics

Website
Website
Employees
Employees
11-50 employees View all
Industry
Industry
Biotechnology
Location
Location
3675 Market St, Suite 200, Philadelphia, Pennsylvania 19104, US
Description
Information
Verismo Therapeutics is pioneering the development of novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer, especially non-hematologic malignancies with few effective therapeutic options. Verismo Therapeutic’s core technology is built upon CARs that are uniquely engineered to more realistically reflect the natural multichain design of killer immunoglobulin-like receptors (KIRs), an important family of immunologic receptors used by T cells and NK cells. Preclinical studies show that SynKIR™-T cells, created by introducing these KIR-based CARs (KIR-CARs) into T cells, more effectively eliminate aggressive tumors in vivo when compared with T cells bearing traditional 2nd generation CAR designs found in current FDA approved CAR-T cell therapies.

Verismo Therapeutics Alternatives

Industry
biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
Biotechnology
Industry
Biotechnology

Frequently Asked Questions about Verismo Therapeutics

What is Verismo Therapeutics email format?

The widely used Verismo Therapeutics email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.


What is Verismo Therapeutics customer service number?

To contact Verismo Therapeutics customer service number call here 215-989-4225. To contact Verismo Therapeutics customer service number in your country click here to find.


Who is the CEO of Verismo Therapeutics?

Bryan Kim is the CEO of Verismo Therapeutics. To contact Bryan Kim email at [email protected] or [email protected]. Or you may call +1.8568668611


Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more